Joel I. Papernik, a Member of the Corporate & Securities Section of Mintz, Cohn, Ferris, Glovsky and Popeo, P.C., is chairing a panel at the 22nd New York Biotechnology Annual Meeting.  The meeting is being held May 29-30 in New York City. 

The panel Mr. Papernik is chairing is entitled, “Starting a Company – Issues to Consider!”

The New York Biotechnology Association (NYBA) is a not-for-profit trade association dedicated to the development and growth of New York State-based biotechnology related industries and institutions, and to strengthening the competitiveness of New York State as a premier global location for biotechnology/biomedical research, education and industry. Its membership is comprised of 250 bioscience companies, world class research institutes and related professional services and biotechnology professionals.

Mr. Papernik has extensive experience counseling high-technology businesses and the individuals creating them. He frequently guides acquisitions, collaborations, and licensing transactions in the life sciences industry..

Mr. Papernik also has functioned as counsel for several publicly and privately held companies in various industries, including media, software, packaged and consumer goods, apparel, financial, packaging, and real estate. In addition to guiding numerous domestic mergers, acquisitions, dispositions, and public offerings to successful conclusions, he has served as US counsel to several overseas firms in connection with establishing U.S. operations, their conduct of public offerings, and their acquisitions in the United States.